illumiSonics and Sunnybrook Launch INOVAIT Focus Fund–Backed Clinical Trial Bringing Label-Free Laser Histology to Mohs Skin Cancer Surgery

First prospective study to validate Multi-Laser Imaging (MLI™) virtual histology against the frozen-section gold standard in a live surgical setting WATERLOO, Ontario & TORONTO — illumiSonics Inc., a medical technology company commercializing label-free tissue imaging, today announced the launch of a prospective clinical validation study at Sunnybrook Health Sciences Centre evaluating its Multi-Laser Imaging (MLI™) […]